A. Tarui et al. / Tetrahedron Letters 49 (2008) 3839–3843
3843
Soc., Perkin Trans 1 1993, 1177–1181; (d) Fluorine-Containing Amino
Acids; Kukhar, V. P., Soloshonok, V. A., Eds.; John Wiley & Sons:
Chichester, 1995; (e) Katritzky, A. R.; Nichols, D. A.; Qi, M.
Tetrahedron Lett. 1998, 39, 7063–7066; (f) Lacroix, S.; Cheguillaume,
13. (a) Hata, S.; Iguchi, M.; Iwasawa, T.; Yamada, K.; Tomioka, K. Org.
Lett. 2004, 6, 1721–1723; (b) Hata, S.; Tomioka, K. Tetrahedron 2007,
63, 8514–8520.
14. Mi, A.; Wang, Z.; Zhang, J.; Jiang, Y. Synth. Commun. 1997, 27,
1469–1473.
´
A.; Gerard, S.; Marchand-Brynaert, J. Synthesis 2003, 16, 2483–
2486.
15. Schwaebe, M. K.; McCarthy, J. R.; Whitten, J. P. Tetrahedron Lett.
2000, 41, 791–794.
6. Uoto, K.; Ohsuki, S.; Takenoshita, H.; Ishiyama, T.; Iimura, S.;
Hirota, Y.; Mitsui, I.; Terasawa, H.; Soga, T. Chem. Pharm. Bull.
1997, 45, 1793–1804.
7. (a) Ojima, I.; Sun, C. M.; Zucco, M.; Park, Y. H.; Duclos, O.; Kuduk,
S. Tetrahedron Lett. 1993, 34, 4149–4152; (b) Holton, R. A.; Kim, H.
B.; Somoza, C.; Liang, F.; Biediger, R. J.; Boatman, P. D.; Shindo,
M.; Smith, C. C.; Kim, S.; Nadizadeh, H.; Suzuki, Y.; Tao, C.; Vu, P.;
Tang, S.; Zhang, P.; Murthi, K. K.; Gentile, L. N.; Liu, J. H. J. Am.
Chem. Soc. 1994, 116, 1599–1600.
8. (a) Marcotte, S.; Pannecoucke, X.; Feasson, C.; Quirion, J. C. J. Org.
Chem. 1999, 64, 8461–8464; (b) Soloshonok, V. A.; Ohkura, H.;
Sorochinsky, A.; Voloshin, N.; Markovsky, A.; Belik, M.; Yamazaki,
T. Tetrahedron Lett. 2002, 43, 5445–5448; (c) Sorochinsky, A.;
Voloshin, N.; Markovsky, A.; Belik, M.; Yasuda, N.; Uekusa, H.;
Ono, T.; Berbasov, D. O.; Soloshonok, V. A. J. Org. Chem. 2003, 68,
7448–7454; (d) Staas, D. D.; Savage, K. L.; Homnick, C. F.; Tsou, N.
N.; Ball, R. G. J. Org. Chem. 2002, 67, 8276–8279; (e) Otaka, A.;
Watanabe, J.; Yukimasa, A.; Sasaki, Y.; Watanabe, H.; Kinoshita,
T.; Oishi, S.; Tamamura, H.; Fujii, N. J. Org. Chem. 2004, 69, 1634–
1645.
9. (a) Andres, J. M.; Martınez, M. A.; Pedrosa, R.; Perez-Encabo, A.
Synthesis 1996, 1070–1072; (b) Kloetzing, R. J.; Thaler, T.; Knochel,
P. Org. Lett. 2006, 8, 1125–1128.
10. (a) Kanai, K.; Wakabayashi, H.; Honda, T. Org. Lett. 2000, 2, 2549–
2551; (b) Kanai, K.; Wakabayashi, H.; Honda, T. Heterocycles 2002,
58, 47–51; (c) Honda, T.; Wakabayashi, H.; Kanai, K. Chem. Pharm.
Bull. 2002, 50, 307–308.
11. (a) Sato, K.; Tarui, A.; Matsuda, S.; Omote, M.; Ando, A.;
Kumadaki, I. Tetrahedron Lett. 2005, 46, 7679–7681; (b) Tarui, A.;
Kondo, K.; Taira, H.; Sato, K.; Omote, M.; Kumadaki, I.; Ando, A.
Heterocycles 2007, 73, 203–208.
12. Boyer, N.; Gloanec, P.; Nanteuil, G. D.; Jubault, P.; Quirion, J. C.
Tetrahedron 2007, 63, 12352–12366.
16. In order to determine the optical purity of difluoro-b-lactam (6a), N-
deprotected difluoro-b-lactam (10a) was used as a standard for chiral
HPLC analysis. The deprotection of 6a was performed by oxidative
cleavage with CAN to give 10a in 70% yield, according to literature
18. Optical purities of difluoro-b-lactams (6a–e) obtained from
aromatic imines were determined by this methodology. On the
analysis of ee for 6f,g obtained from aliphatic imines, difluoro-b-
lactams were analyzed directly by chiral HPLC. Chiral HPLC: Daicel
Chiralcel OD-H column (4.6 mm£, 250 mm), isopropanol/hexane =
9:1, wavelength: 254 nm, flow rate: 0.8 mL/min, retention time:
18.9 min ((R)-10a), 38.9 min ((S)-10a).
PMB
Ph
H
O
O
CAN
N
N
F
F
CH3CN - H2O
*
*
6a
Ph
F
F
10a
17. Typical procedure is as follows: under an Ar atmosphere, 2 (938 mg,
3 mmol) was added to the solution of imine (5a, 225 mg, 1 mmol) and
RhCl(PPh3)3 (9 mg, 0.01 mmol) in THF (8 mL) at ꢀ10 °C, then the
mixture was stirred for 30 min. Then, 1.0 M Et2Zn in hexane (3 mL,
3 mmol) was slowly added to the mixture. The mixture was stirred for
2 h at the same temperature, and was quenched with saturated
aqueous NaHCO3. The mixture was filtered through Celite layer, and
the filtrate was extract with AcOEt. The extract was washed with
brine and dried over MgSO4. Concentration of the dried layer in
vacuo followed by flush chromatography on silica gel (AcOEt/
hexane = 2:8) gave the corresponding product (6a, 214 mg, 71%).
18. For removal of PMB or PMP group, see: (a) Wright, J. A.; Yu, J.;
Spencer, J. B. Tetrahedron Lett. 2001, 42, 4033–4036; (b) Buttero, P.
D.; Molteni, G.; Pilati, T. Tetrahedron 2005, 61, 2413–2419.
´
´
´